Skip to content
10-Q

Quarterly Report

Aevi Genomic Medicine, Inc.

0001144204-19-025777

← back to feed
Filed
May 14, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2019 · May 9, 2019 64.77M sh
Capex Q1 2019 · Mar 31, 2019 $0
Capex Q1 2019 · Mar 31, 2018 $0
Operating Cash Flow Q1 2019 · Mar 31, 2019 −$5.13M
Operating Cash Flow Q1 2019 · Mar 31, 2018 −$7.24M
Cash And Equivalents Q1 2019 · Mar 31, 2019 $6.95M
Cash And Equivalents Q1 2019 · Dec 31, 2018 $12.08M
Cash And Equivalents Q1 2019 · Mar 31, 2018 $26.52M
Cash And Equivalents Q1 2019 · Dec 31, 2017 $33.73M
Stockholders Equity Q1 2019 · Mar 31, 2019 $3.72M
Stockholders Equity Q1 2019 · Dec 31, 2018 $7.93M
Stockholders Equity Q1 2019 · Mar 31, 2018 $22.7M
Stockholders Equity Q1 2019 · Dec 31, 2017 $30.62M
Current Liabilities Q1 2019 · Mar 31, 2019 $3.9M
Current Liabilities Q1 2019 · Dec 31, 2018 $4.35M
Total Liabilities Q1 2019 · Mar 31, 2019 $3.9M
Total Liabilities Q1 2019 · Dec 31, 2018 $4.35M
Current Assets Q1 2019 · Mar 31, 2019 $7.6M
Current Assets Q1 2019 · Dec 31, 2018 $12.25M
Total Assets Q1 2019 · Mar 31, 2019 $7.62M
Total Assets Q1 2019 · Dec 31, 2018 $12.28M
Sga Expense Q1 2019 · Mar 31, 2019 $1.69M
Sga Expense Q1 2019 · Mar 31, 2018 $2.17M
Rd Expense Q1 2019 · Mar 31, 2019 $1.33M
Rd Expense Q1 2019 · Mar 31, 2018 $2.59M
Net Income Q1 2019 · Mar 31, 2019 −$4.84M
Net Income Q1 2019 · Mar 31, 2018 −$8.71M
Operating Income Q1 2019 · Mar 31, 2019 −$4.85M
Operating Income Q1 2019 · Mar 31, 2018 −$8.74M